Improvement in corneal scarring following bacterial keratitis

Eye (Basingstoke)

Volumn 27, Issue 3, 2013, Pages 443-446

  McClintic, S M ^a   Srinivasan, M ^b   Mascarenhas, J ^b   Greninger, D A ^a   Acharya, N R ^a,c   Lietman, T M ^a,c   Keenan, J D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARAVIND EYE CARE SYSTEM   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

corneal scar; corneal ulcer; SCUT

Indexed keywords

MOXIFLOXACIN; PLACEBO; PREDNISOLONE SODIUM PHOSPHATE;

ADULT; AGED; ARTICLE; BACTERIAL KERATITIS; CONTACT LENS; CONTROLLED STUDY; CORNEA DISEASE; CORNEA OPACITY; CORNEA SCAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RANDOMIZED CONTROLLED TRIAL; SCAR; TREATMENT OUTCOME; VISION; VISUAL ACUITY;

EID: 84875153188     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.270     Document Type: Article

References (5)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851. (Pubitemid 39573742)
2. Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade. Indian J Ophthalmol 2009; 57: 273-279.
3. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV et al. Corticosteroids for bacterial keratitis: The Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol 2012; 130: 143-150.
4. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV et al. The steroids for corneal ulcers trial: Study design and baseline characteristics. Arch Ophthalmol 2012; 130: 151-157.
5. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res 2010; 91: 326-335.